Glaxo Group Ltd. operates through its subsidiary Glaxo Laboratories Ltd. that engages in the production of food products for infants such as Ostermilk, Complan, Casilan, Farex. Glaxo Group Ltd. was formerly known as Glaxo Laboratories Ltd. and changed its name to Glaxo Group Ltd. in 1962. The company is based in Brentford, United Kingdom. Glaxo Group Ltd. operates as a subsidiary of Glaxosmithkline plc.

Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy.

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

MC2 Therapeutics Ltd., part of Mc2 Therapeutics AS, is a British company located in Leatherhead. The firm develops pharmaceutical products for chronic inflammatory conditions. It was founded in 2005.\nThe company says this about itself: MC2 Therapeutics is a privately held commercial stage pharmaceutical company developing a new standard of topical therapies for chronic inflammatory conditions. Using its PAD�� Technology it aims to set a new standard of treatment experience for patients and to release the full potential of novel topical drugs for the benefit of patients, physicians, payers, and societies. PAD�� Technology is the basis for its innovative pipeline of drug candidates within atopic dermatitis, uremic pruritus, lichen sclerosus and dry eye. PAD�� Technology enables a new type of cream that provides key features in topical therapies for chronic inflammatory conditions thereby releasing the full potential of the therapy.

Senju USA is a pharmaceutical company in the field of ophthalmology.

Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments. The Specialized BioTherapeutics segment focuses on the development of a novel photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Public Health Solutions segment consists of active development programs for RiVax, a ricin toxin vaccine candidate, and SGX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease. The company was founded in 1987 and is headquartered Princeton, NJ.

Chongqing Huapont Pharmaceutical Co. Ltd., part of Huapont Life Sciences Co., Ltd., is a company headquartered in Chongqing, China. The firm manufactures pharmaceutical products.

Glaxo Wellcome SA, a subsidiary of GSK Plc, is a company headquartered in Aranda de Duero, Spain. The firm manufactures and markets medicines.

Smithkline Beckman Corp, part of GSK Plc, is an American company located in Philadelphia, PA, involved in pharmaceutical preparations. On July 27, 1989 Smithkline Beecham Plc acquired Smithkline Beckman Corp for $16,082.37 million.

Part of GSK Plc, Laboratorios Dermatol��gicos Darier SA de CV is a Mexican company located in Mexico City specializing in pharmaceutical preparations. Ricardo Jesus Spinola Sevilla is currently the CEO of the firm.

Tianjin Jinyao Group Co. Ltd. is a Chinese private company located in Tianjin. The firm manufactures pharmaceutical products.

Hunan Kerey Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical intermediates. Its products include special active pharmaceutical ingredients, plant-origin cholesterol and vitamin D, plant-origin cholic acids, brassinolides, and key intermediates. The company was founded in 2005 and is headquartered in Shaoyang, China.

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Fisons plc was a British multinational pharmaceutical, scientific instruments and horticultural chemicals company headquartered in Ipswich, United Kingdom. It was listed on the London Stock Exchange and was once a constituent of the FTSE 100 Index. It was acquired by Rhone-Poulenc in 1995.

TOLMAR is a northern Colorado based pharmaceutical research, development, manufacturing and commercial operations company. TOLMAR develops and manufacturers both proprietary and generic pharmaceutical products with specific focus in therapeutic areas of dental, dermatology, and oncology products.

Henan Lihua Pharmaceutical Co. Ltd. manufactures and distributes glucocorticoid active pharmaceutical ingredients and related intermediates. Its products include prednisolone, prednisone, hydrocortisone, betamethasone and their derivatives. The company is headquartered in Anyang, China.

Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Over the decades, we have established ourselves as a leading player in the discovery of new molecules both NCEs (New Chemical Entity) and NBEs (New Biological Entity). They have several molecules in various stages of pre-clinical and clinical development and are primarily focused in the areas of Oncology, Respiratory and Dermatology.